BeiGene Forms Drug Delivery and Patient Communication Partnership with 111
March 18, 2021 at 05:47 AM EDT
BeiGene, a Beijing oncology company, will collaborate with Shanghai 's 111 Inc. to develop an Internet + Medicine & Healthcare model to support distribution of BeiGene's products. The companies will use 111's online platform to advertise BeiGene's drugs in China and deliver medications using its online and offline direct-to-patient (DTP) delivery service. They will also develop a patient management system to improve care, especially for patients outside of the hospital. At the moment, BeiGene has two novel approved products in China . More details.... Stock Symbols: (NSDQ: BGNE; HK:06160) (NSDQ: YI) Share this with colleagues: // //
